CHPT
ChargePoint Holdings, Inc.
CHPT has the edge over RIVN overall, supported by stronger fundamentals and stronger modeled upside.
RIVN
Rivian Automotive, Inc.
RIVN has lower modeled downside risk, despite its lower overall score.
CHPT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Under pressure | |
| Unavailable |
CHPT's revenue is currently healthy, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
RIVN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
RIVN's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
CHPT PE Valuation
CHPT has no meaningful PE right now: it lost money over the past year.
RIVN PE Valuation
RIVN has no meaningful PE right now: it lost money over the past year.
CHPT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect CHPT's losses to shrink, with revenue growing.
RIVN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RIVN's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
CHPT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$7.26 | +$4.19 |
| Q2 2026 | -$8.76 | +$3.04 |
| Q1 2026 | -$9.41 | +$3.39 |
| Q4 2025 | -$10.08 | +$4.32 |
| Q3 2025 | -$11.45 | +$7.95 |
| Q2 2025 | -$11.80 | +$11.40 |
| Q1 2025 | -$12.80 | +$11.60 |
| Q4 2024 | -$14.40 | +$10.20 |
CHPT is still losing money, but far less than before: $7.26 per share over the past year, against $29.80 at its worst in early 2022.
RIVN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.25 | +$0.83 |
| Q2 2026 | -$2.58 | +$0.62 |
| Q1 2026 | -$2.92 | +$0.77 |
| Q4 2025 | -$3.07 | +$1.62 |
| Q3 2025 | -$3.08 | +$2.52 |
| Q2 2025 | -$3.20 | +$2.76 |
| Q1 2025 | -$3.69 | +$2.08 |
| Q4 2024 | -$4.69 | +$1.05 |
RIVN is still losing money, but far less than before: $2.25 per share over the past year, against $7.40 at its worst in late 2022.
CHPT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $116.1M | +18% |
| Q2 2026 | $101.8M | +4.3% |
| Q1 2026 | $109.3M | +7.3% |
| Q4 2025 | $105.7M | +6.1% |
| Q3 2025 | $98.6M | -9.2% |
| Q2 2025 | $97.6M | -8.8% |
| Q1 2025 | $101.9M | -12% |
| Q4 2024 | $99.6M | -9.7% |
CHPT's revenue is recovering but still below its 2023 peak: $116M last quarter, up 18% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -29% | +31 points |
| Q2 2026 | -46% | +8.8 points |
| Q1 2026 | -48% | +5.5 points |
| Q4 2025 | -42% | +27 points |
| Q3 2025 | -60% | -2 points |
| Q2 2025 | -55% | +7.6 points |
| Q1 2025 | -54% | +26 points |
| Q4 2024 | -68% | +71 points |
CHPT has the edge over RIVN on profitability, with a higher operating margin.
RIVN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.2B | +38% |
| Q2 2026 | $1.7B | +27% |
| Q1 2026 | $1.4B | +11% |
| Q4 2025 | $1.3B | -26% |
| Q3 2025 | $1.6B | +78% |
| Q2 2025 | $1.3B | +13% |
| Q1 2025 | $1.2B | +3% |
| Q4 2024 | $1.7B | +32% |
RIVN has the edge over CHPT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -41% | +22 points |
| Q2 2026 | -50% | +35 points |
| Q1 2026 | -64% | -11 points |
| Q4 2025 | -65% | -27 points |
| Q3 2025 | -63% | +71 points |
| Q2 2025 | -86% | +33 points |
| Q1 2025 | -53% | +70 points |
| Q4 2024 | -38% | +82 points |
RIVN's operating margin was −41% last quarter, up 22 points from the same quarter a year ago, near the top of its range since 2021.
CHPT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$5.2M | +$2.3M |
| Q2 2026 | -$37.7M | -$3.7M |
| Q1 2026 | -$2M | +$2.6M |
| Q4 2025 | -$23.6M | +$9.8M |
| Q3 2025 | -$7.5M | +$47.5M |
| Q2 2025 | -$34M | +$32M |
| Q1 2025 | -$4.6M | +$41.6M |
| Q4 2024 | -$33.4M | +$68.3M |
CHPT has the edge over RIVN on cash flow, with more consistent year-over-year improvement.
RIVN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.1B | -$703M |
| Q2 2026 | -$849M | -$451M |
| Q1 2026 | -$1.1B | -$549M |
| Q4 2025 | -$1.1B | -234% |
| Q3 2025 | -$421M | +$732M |
| Q2 2025 | -$398M | +$639M |
| Q1 2025 | -$526M | +$997M |
| Q4 2024 | $856M | +$2.3B |
RIVN has burned cash in almost every quarter: −$4.2B over the past year, against −$489M the year before.
CHPT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +6.9% | +1.7M shares |
| 1 year | +13% | +3.1M shares |
| 3 years | +48% | +8.5M shares |
| 5 years | +68% | +10.6M shares |
CHPT has the edge over RIVN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
RIVN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +9.1% | +121M shares |
| 1 year | +19% | +226M shares |
| 3 years | +52% | +494M shares |
RIVN has 1.4B diluted shares, up 19% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | $6M |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
CHPT Net Leverage
CHPT's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
RIVN Net Leverage
RIVN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CHPT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 65.1 | Neutral |
| Stochastic | 84.4 | Overbought |
CHPT's weekly RSI is 65 (neutral) and its Stochastic is 84 (overbought).
RIVN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 25.6 | Neutral |
RIVN's weekly RSI is 41 (neutral) and its Stochastic is 26 (neutral).
CHPT PE vs Consumer Cyclical Sector
CHPT has no meaningful PE right now: it lost money over the past year.
RIVN PE vs Consumer Cyclical Sector
RIVN has no meaningful PE right now: it lost money over the past year.
CHPT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.32 | 29% above |
| 20 week MA | $7.81 | 54% above |
| 50 week MA | $7.08 | 70% above |
| 100 week MA | $10.4 | 16% above |
| 200 week MA | $49.3 | 76% below |
CHPT has the edge over RIVN on trend strength, trading above more of its moving averages.
RIVN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.3 | 3.9% below |
| 20 week MA | $15.1 | 15% below |
| 50 week MA | $15.9 | 19% below |
| 100 week MA | $14.7 | 13% below |
| 200 week MA | $15.1 | 15% below |
RIVN is in a downtrend: it's below all five of its weekly moving averages, and 15% below its 200-week average.
CHPT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $196.0 | $922.0 | +370% |
| 2021 | $922.0 | $381.0 | -59% |
| 2022 | $381.0 | $171.0 | -55% |
| 2023 | $171.0 | $46.8 | -73% |
| 2024 | $46.8 | $22.8 | -51% |
| 2025 | $22.8 | $7.08 | -69% |
| 2026 YTD | $7.08 | $12.1 | +70% |
CHPT has the edge over RIVN on returns for 2026, with the stronger performance.
RIVN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $130.0 | $96.8 | -25% |
| 2022 | $96.8 | $19.1 | -80% |
| 2023 | $19.1 | $23.5 | +23% |
| 2024 | $23.5 | $13.7 | -42% |
| 2025 | $13.7 | $20.9 | +53% |
| 2026 YTD | $20.9 | $12.8 | -39% |
RIVN has finished lower in three of the last five years. It's down 39% so far in 2026.